Sign Up Today and Learn More About PIQUR Therapeutics Stock
Invest in or calculate the value of your shares in PIQUR Therapeutics or other pre-IPO companies through EquityZen's platform.
PIQUR Therapeutics Stock
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
About PIQUR Therapeutics Stock
Founded
2011
Total Funding
85.8M
Industries
Software, Data and Analytics, Artificial Intelligence
PIQUR Therapeutics Press Mentions
Stay in the know about the latest news on PIQUR Therapeutics
Treatment of skin lesions
patents • Apr 14, 2024
Cancer Janus Kinase Inhibitors Market Size, Share, Scope ...
artrocker • Dec 19, 2023
Cancer mTOR Inhibitors Market Size, Predicting Trends and ...
artrocker • Dec 19, 2023
Versant Ventures invests CHF 11 million in PIQUR
startupticker • Jul 11, 2018
Additional milestone for PIQUR's lead compound
startupticker • Apr 30, 2017
PIQUR Therapeutics Management
Leadership team at PIQUR Therapeutics
Chief Scientific Officer
Doriano Fabbro
Head BD & Communications
Tatsuo Satoh
Join now and verify your accreditation status to gain access to:
- PIQUR Therapeutics current valuation
- PIQUR Therapeutics stock price
- Available deals in PIQUR Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in PIQUR Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like PIQUR Therapeutics through EquityZen funds. These investments are made available by existing PIQUR Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell PIQUR Therapeutics stock?
Shareholders can sell their PIQUR Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
